Exelixis, Inc. (EXEL)

41.61 +0.23 (+0.56%) USD  |  NASDAQ  |  Dec 16, 14:47
More

Exelixis Price Target Upside (Daily)

Price Target Upside (Daily) Chart

View Price Target Upside (Daily) for EXEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Upside (Daily) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Upside (Daily) Range, Past 5 Years

View Price Target Upside (Daily) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Upside (Daily) Benchmarks

View Price Target Upside (Daily) Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Aldeyra Therapeutics, Inc. Upgrade
Merck & Co., Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade